Coronavirus Disease Pathophysiology: Biomarkers, Potential New Remedies, Comorbidities, Long COVID-19, Post Pandemic Epidemiological Surveillance

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Aug 12

PMID 37569612

Authors

Jacek Z Kubiak

Malgorzata Kloc

Affiliations

Soon will be listed here.

Abstract

The toughest challenge modern biomedical research ever faced was the rapid understanding of the SARS-CoV-2 physiopathology [...].

Citing Articles

Haematological Manifestations of SARS-CoV-2: Insights into Erythropoiesis, Hepcidin Regulation, and Cytokine Storm.

Parham E, Ahmad M, Falasca M Int J Mol Sci. 2025; 26(3).

PMID: 39940645 PMC: 11817086. DOI: 10.3390/ijms26030874.

Multi-epitope vaccine against SARS-CoV-2 targeting the spike RBD: an immunoinformatics approach.

Pahlavan Y, Yeganeh O, Asghariazar V, Karami C Future Sci OA. 2024; 10(1):FSO939.

PMID: 38827807 PMC: 11140640. DOI: 10.2144/fsoa-2023-0081.

References

Dufrusine B, Valentinuzzi S, Bibbo S, Damiani V, Lanuti P, Pieragostino D . Iron Dyshomeostasis in COVID-19: Biomarkers Reveal a Functional Link to 5-Lipoxygenase Activation. Int J Mol Sci. 2023; 24(1). PMC: 9819889. DOI: 10.3390/ijms24010015. View

Netea M, Giamarellos-Bourboulis E, Dominguez-Andres J, Curtis N, van Crevel R, van de Veerdonk F . Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection. Cell. 2020; 181(5):969-977. PMC: 7196902. DOI: 10.1016/j.cell.2020.04.042. View

Fulinski A . Weak Point of SARS-CoV-2: Human and Viral Ion Channels under External Physical Fields. Int J Mol Sci. 2022; 23(23). PMC: 9737394. DOI: 10.3390/ijms232315185. View

Costantini S, Madonna G, Di Gennaro E, Capone F, Bagnara P, Capone M . New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer. Int J Mol Sci. 2023; 24(5). PMC: 10003544. DOI: 10.3390/ijms24054922. View

Domotor O, Enyedy E . Evaluation of In Vitro Distribution and Plasma Protein Binding of Selected Antiviral Drugs (Favipiravir, Molnupiravir and Imatinib) against SARS-CoV-2. Int J Mol Sci. 2023; 24(3). PMC: 9917862. DOI: 10.3390/ijms24032849. View

Boschi C, Scheim D, Bancod A, Militello M, Bideau M, Colson P . SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects. Int J Mol Sci. 2022; 23(24). PMC: 9779393. DOI: 10.3390/ijms232415480. View

Urazov S, Chernov A, Popov O, Klenkova N, Sushentseva N, Polkovnikova I . Secretory Phospholipase A2 and Interleukin-6 Levels as Predictive Markers of the Severity and Outcome of Patients with COVID-19 Infections. Int J Mol Sci. 2023; 24(6). PMC: 10059025. DOI: 10.3390/ijms24065540. View

Larsson A, Hultstrom M, Frithiof R, Lipcsey M, Eriksson M . Shrunken Pore Syndrome Is Frequently Occurring in Severe COVID-19. Int J Mol Sci. 2022; 23(24). PMC: 9779236. DOI: 10.3390/ijms232415687. View

Hutanu A, Manu D, Gabor M, Vasiesiu A, Andrejkovits A, Dobreanu M . Dynamic Evaluation of Natural Killer Cells Subpopulations in COVID-19 Patients. Int J Mol Sci. 2022; 23(19). PMC: 9569797. DOI: 10.3390/ijms231911875. View

10.

Carstens L, DAmico R, de Moura K, Morais de Castro E, Centenaro F, Silva Barbosa G . Lung Inflammasome Activation in SARS-CoV-2 Post-Mortem Biopsies. Int J Mol Sci. 2022; 23(21). PMC: 9659061. DOI: 10.3390/ijms232113033. View

11.

Zapolnik P, Kmiecik W, Mazur A, Czajka H . Trained Immunity, BCG and SARS-CoV-2 General Outline and Possible Management in COVID-19. Int J Mol Sci. 2023; 24(4). PMC: 9961109. DOI: 10.3390/ijms24043218. View

12.

Alzahrani F, Khan M, Ahmad V . Recognition of Differentially Expressed Molecular Signatures and Pathways Associated with COVID-19 Poor Prognosis in Glioblastoma Patients. Int J Mol Sci. 2023; 24(4). PMC: 9965082. DOI: 10.3390/ijms24043562. View

13.

Jevnikar K, Meglic A, Lapajne L, Logar M, Vidovic Valentincic N, Petrovic M . The Comparison of Retinal Microvascular Findings in Acute COVID-19 and 1-Year after Hospital Discharge Assessed with Multimodal Imaging-A Prospective Longitudinal Cohort Study. Int J Mol Sci. 2023; 24(4). PMC: 9966689. DOI: 10.3390/ijms24044032. View

14.

Carlson E, Macsai M, Bertrand S, Bertrand D, Nau J . The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline. Int J Mol Sci. 2023; 24(6). PMC: 10051900. DOI: 10.3390/ijms24065597. View

15.

Gonzalez-Cuadrado C, Caro-Espada P, Chivite-Lacaba M, Utrero-Rico A, Lozano-Yuste C, Gutierrez-Solis E . Hemodialysis-Associated Immune Dysregulation in SARS-CoV-2-Infected End-Stage Renal Disease Patients. Int J Mol Sci. 2023; 24(2). PMC: 9865754. DOI: 10.3390/ijms24021712. View

16.

Urbiola-Salvador V, Lima de Souza S, Gresner P, Qureshi T, Chen Z . Plasma Proteomics Unveil Novel Immune Signatures and Biomarkers upon SARS-CoV-2 Infection. Int J Mol Sci. 2023; 24(7). PMC: 10093853. DOI: 10.3390/ijms24076276. View

17.

Kalinskaya A, Vorobyeva D, Rusakovich G, Maryukhnich E, Anisimova A, Dukhin O . Targeted Blood Plasma Proteomics and Hemostasis Assessment of Post COVID-19 Patients with Acute Myocardial Infarction. Int J Mol Sci. 2023; 24(7). PMC: 10094800. DOI: 10.3390/ijms24076523. View

18.

Sun X, Quan L, Chen R, Liu D . Direct Interaction of Coronavirus Nonstructural Protein 3 with Melanoma Differentiation-Associated Gene 5 Modulates Type I Interferon Response during Coronavirus Infection. Int J Mol Sci. 2022; 23(19). PMC: 9570369. DOI: 10.3390/ijms231911692. View

19.

Darwish S, Liu L, Robinson T, Tarugu S, Owings A, Glover S . COVID-19 Plasma Extracellular Vesicles Increase the Density of Lipid Rafts in Human Small Airway Epithelial Cells. Int J Mol Sci. 2023; 24(2). PMC: 9861961. DOI: 10.3390/ijms24021654. View

20.

Georgieva E, Atanasov V, Kostandieva R, Tsoneva V, Mitev M, Arabadzhiev G . Direct Application of 3-Maleimido-PROXYL for Proving Hypoalbuminemia in Cases of SARS-CoV-2 Infection: The Potential Diagnostic Method of Determining Albumin Instability and Oxidized Protein Level in Severe COVID-19. Int J Mol Sci. 2023; 24(6). PMC: 10058219. DOI: 10.3390/ijms24065807. View